<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12737/article_59f0360ea55615.08082149</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-401</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЛУЧАЙ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Клинико-экспертный случай эозинофильного гранулематозного васкулита</article-title><trans-title-group xml:lang="en"><trans-title>Clinical expert case of eosinophilic granulomatous vasculitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каретникова</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Karetnikova</surname><given-names>V. M.</given-names></name></name-alternatives><email xlink:type="simple">vik-karet@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрунько</surname><given-names>И. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrunko</surname><given-names>I. L.</given-names></name></name-alternatives><email xlink:type="simple">petrunkoirina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутская государственная медицинская академия последипломного образования -филиал ФГБОУ «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Russian Medical Academy of Continuing Professional Education</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2017</year></pub-date><volume>2</volume><issue>3</issue><fpage>106</fpage><lpage>109</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Каретникова В.М., Петрунько И.Л., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Каретникова В.М., Петрунько И.Л.</copyright-holder><copyright-holder xml:lang="en">Karetnikova V.M., Petrunko I.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/401">https://www.actabiomedica.ru/jour/article/view/401</self-uri><abstract><p>В статье представлен сложный клинико-экспертный случай эозинофильного гранулематозного ANCA-негативного полиангиита, демонстрирующий затруднения при проведении медико-социальной экспертизы, т. к. в действующих нормативных документах не предусмотрен системный васкулит. Поэтому количественная оценка стойких функциональных нарушений при представленном многосистемном поражении проводилась индивидуально по наличию выраженных нарушений функции дыхания (70 %) и поражению центральной и периферической нервной системы.</p></abstract><trans-abstract xml:lang="en"><p>The article is an example of individual approach to medical-social examination (MSE) of the patient with eosinophilic granulomatous with polyangiitis (EGPA) that represents the difficulty in the absence of a strictly regulated order of the criteria in systemic vasculitis. Implications of illness at the patient were presented by bronchial asthma, a bilateral hydrothorax, pericarditis, displays of polyneuropathy, and eosinophilia. Therapy by Prednisolonum of 40 mg in within a year has not allowed to achieve reduction of process activity. The hydrothorax recurred. There were signs of central nervous system impairment; the psychiatrist diagnosed organic emotional and labile disorder of vascular genesis with moderate emotional-volitional and mnestic-intellectual decrease. When conducting MSE there were difficulties at quantitative assessment of disturbances, due to the lack of EGPA in the annex to the existing order. Therefore, the decision to establish the second group of disability has been made by specialists of MSE bureau. As the patient suffers from recurrent hydrothorax, a pulmonitis, persistent obstruction of bronchi of average degree of expression, the anoxemia that is indirectly determined by depression of a saturation of oxygen to 94 %, expressed respiration dysfunction (70 %) has been established, as well as impairment of CNS and the peripheral nervous system. The forecast for convalescence is adverse. The forecast for life - rather favorable, because the heart and kidneys are not affected.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эозинофильный гранулематоз с полиангиитом</kwd><kwd>медико-социальная экспертиза</kwd><kwd>инвалидность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>eosinophilic granulomatosis with polyangiitis</kwd><kwd>medical and social assessment</kwd><kwd>disability</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бекетова Т.В., Волков М.Ю., Насонов Е.Л. Современные подходы к диагностике и лечению эозинофильного гранулематоза с полиангиитом: международные рекомендации 2015 г. // Терапевтический архив. - 2016. - Т. 88, № 5. - С. 86-92</mixed-citation><mixed-citation xml:lang="en">Бекетова Т.В., Волков М.Ю., Насонов Е.Л. Современные подходы к диагностике и лечению эозинофильного гранулематоза с полиангиитом: международные рекомендации 2015 г. // Терапевтический архив. - 2016. - Т. 88, № 5. - С. 86-92</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Каретникова В.М., Петрунько И.Л. Вопросы медико-социальной экспертизы при заболеваниях органов дыхания. - Иркутск: РИО ИГМАПО, 2015. -С. 63-71</mixed-citation><mixed-citation xml:lang="en">Каретникова В.М., Петрунько И.Л. Вопросы медико-социальной экспертизы при заболеваниях органов дыхания. - Иркутск: РИО ИГМАПО, 2015. -С. 63-71</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мэскел Н., Миллар Э. Руководство по респираторной медицине. - М.: ГЭОТАР-Медиа, 2013.-С. 571-574</mixed-citation><mixed-citation xml:lang="en">Мэскел Н., Миллар Э. Руководство по респираторной медицине. - М.: ГЭОТАР-Медиа, 2013.-С. 571-574</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">О классификациях и критериях, используемых при осуществлении медико-социальной экспертизы граждан федеральными государственными учреждениями медико-социальной экспертизы. Приказ Министерства труда и социальной защиты РФ № 1024н от 17.12.2015 г. (с изменениями от 5.07.2016 г.)</mixed-citation><mixed-citation xml:lang="en">О классификациях и критериях, используемых при осуществлении медико-социальной экспертизы граждан федеральными государственными учреждениями медико-социальной экспертизы. Приказ Министерства труда и социальной защиты РФ № 1024н от 17.12.2015 г. (с изменениями от 5.07.2016 г.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральные клинические рекомендации по диагностике системных васкулитов / Под ред. Е.Н. Насонова. - М., 2013. - 29 с</mixed-citation><mixed-citation xml:lang="en">Федеральные клинические рекомендации по диагностике системных васкулитов / Под ред. Е.Н. Насонова. - М., 2013. - 29 с</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Цыбикова С.В., Страмбовкая Н.Н. Эпидемиология заболеваний периферической нервной системы по данным МУЗ ГБ БСМП, г. Улан-Удэ за 2006-2007 гг. // Бюл. ВСНЦ СО РАМН. - 2008. - № 3 (61).- С. 171-172</mixed-citation><mixed-citation xml:lang="en">Цыбикова С.В., Страмбовкая Н.Н. Эпидемиология заболеваний периферической нервной системы по данным МУЗ ГБ БСМП, г. Улан-Удэ за 2006-2007 гг. // Бюл. ВСНЦ СО РАМН. - 2008. - № 3 (61).- С. 171-172</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P., French Vasculitis Study Group (FVSG). (2011). The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore), 90 (1), 19-27. doi: 10.1097/MD.0b013e318205a4c6</mixed-citation><mixed-citation xml:lang="en">Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P., French Vasculitis Study Group (FVSG). (2011). The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore), 90 (1), 19-27. doi: 10.1097/MD.0b013e318205a4c6</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kränke B., Aberer W. (1997). Macrolide-induced Churg - Strauss syndrome in patient with atopy. Lancet, 350, 1551-1552. doi: 10.1016/s0140-6736(05)63984-0.</mixed-citation><mixed-citation xml:lang="en">Kränke B., Aberer W. (1997). Macrolide-induced Churg - Strauss syndrome in patient with atopy. Lancet, 350, 1551-1552. doi: 10.1016/s0140-6736(05)63984-0.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mahr A., Moosig F., Neumann T., Szczeklik W., Taillé C., Vaglio A. (2014) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr. Opin. Rheumatol., 26 (1), 16-23. doi: 10.1097/BOR.0000000000000015.</mixed-citation><mixed-citation xml:lang="en">Mahr A., Moosig F., Neumann T., Szczeklik W., Taillé C., Vaglio A. (2014) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr. Opin. Rheumatol., 26 (1), 16-23. doi: 10.1097/BOR.0000000000000015.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Moosig F., Bremer J.P., Hellmich B., Holle J.U., Holl-Ulrich K., Laudien M., Matthis C., Metzler C., Nölle B., Richardt G., Gross W.L. (2013). A vasculitis centre-based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis., 72 (6), 1011-1017.</mixed-citation><mixed-citation xml:lang="en">Moosig F., Bremer J.P., Hellmich B., Holle J.U., Holl-Ulrich K., Laudien M., Matthis C., Metzler C., Nölle B., Richardt G., Gross W.L. (2013). A vasculitis centre-based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis., 72 (6), 1011-1017.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Saech J., Owczarczyk K., Roesgen S., Hallek M., Rubbert A. (2010). Successful use of rituximab in a patient with Churg - Strauss syndrome and refractory central nervous system involvement. Ann. Rheum. Dis., 69 (6), 1254-1255.</mixed-citation><mixed-citation xml:lang="en">Saech J., Owczarczyk K., Roesgen S., Hallek M., Rubbert A. (2010). Successful use of rituximab in a patient with Churg - Strauss syndrome and refractory central nervous system involvement. Ann. Rheum. Dis., 69 (6), 1254-1255.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Stern M., Pagnoux C., Mouthon L., Guillevin L., French Vasculitis Study Group. (2013). Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg - Strauss syndrome) enrolled in two prospective trials. J. Autoimmun., 43, 60-69. doi: 10.1016/j.jaut.2013.03.003.</mixed-citation><mixed-citation xml:lang="en">Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Stern M., Pagnoux C., Mouthon L., Guillevin L., French Vasculitis Study Group. (2013). Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg - Strauss syndrome) enrolled in two prospective trials. J. Autoimmun., 43, 60-69. doi: 10.1016/j.jaut.2013.03.003.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
